NorthWest Biotherapeutics Inc (NWBO)

[ccie1024]

"...late stage parallel negotiations with different unrelated third parties..."

Hi Doc -

At the risk of getting too excited again, I sincerely feel the wink and nod here:

* "late stage... negotiations" - advanced, mature.
* "parallel negotiations" - multiple simultaneous negotiations
* "different unrelated... parties" - multiple, well, parties
* "alternative potential financings" - one or more could be consummated

The company is asked to disclose in "reasonable detail" the reasons for the NT filing. I think there is more detail than necessary, in my opinion (hey - does that make me a KOL like the rest of you?). Compare to

May's NT: "could not complete its quarter end procedures without undue hardship and expense given an accounting issue that arose late in the process concerning a variable interest entity analysis related to a recent agreement"

April's NT: "the Company and its auditors were required to conduct additional procedures"

November's NT: "requires additional time to complete its accounting review of this appraisal"

August '17's NT: " conduct a more detailed analysis under ASC 360"

The previous reasons sound more like creative excuses, based on the unexpected. This one sounds more planned.